Alyftrek 10-50-125 MG tablet 14S

Ended Awarded Last action

Contract number
SPE2DR26FKRN1
Awardee
Awarding agency
Obligated
$21,425

Award facts

Contract value 100% obligated
$21,425.03 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $21,425.03 delivery order to DMS Pharmaceutical Group Inc. on May 18, 2026, for ALYFTREK 10-50-125 MG tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical is a woman-owned small business holding the single-award indefinite delivery contract (SPE2DX) under PPV-G GEN V, a Defense Logistics Agency pharmaceutical supply program with a $499.999 billion ceiling extending through December 31, 2036. Place of performance is Park Ridge, Illinois. The order carries a firm fixed price and an ultimate completion date of May 19, 2026. No set-aside applies to this order.

Quick answers

Who was awarded contract SPE2DR26FKRN1?

SPE2DR26FKRN1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 18, 2026.

How much is contract SPE2DR26FKRN1 worth?

The government has obligated $21,425 on SPE2DR26FKRN1.

Is contract SPE2DR26FKRN1 an order under another contract?

Yes. SPE2DR26FKRN1 is a delivery order under SPE2DR25D9230, an indefinite delivery contract.

Was contract SPE2DR26FKRN1 competed?

The extent of competition for SPE2DR26FKRN1 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award